Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Webmd Health Corp Issues FY 2012 Guidance; Net Loss Guidance Above Analysts' Estimates; Issues Q4 2012 Guidance
Webmd Health Corp announced that for fiscal 2012, it expects revenue of $455 to $475 million, adjusted EBITDA to be $60.0 to $70.0 million; and loss from continuing operations is expected to be $(21.9) to $(14.6), net loss is expected to be $(19.2)-$(11.9) and loss per share of $(0.38)-$(23). For the fourth quarter of 2012, it expects revenue to be between $118 million to $133 million, adjusted EBITDA as a percentage of revenue is forecasted to be approximately 14% to 20% and (Loss) income from continuing operations as a percentage of revenue is to be approximately (5%) to 2%. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $462 million, EBITDA of $63.2 million and net income of $(19.7) million for fiscal 2012; and revenues of $126 million, EBITDA of $22.7 million and net income of $(0.41) million for the fourth quarter of 2012.
Latest Developments for WebMD Health Corp
- Share this
- Link this
- Digg this


Follow Reuters